| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $11.87T | $10.84T | $9.97T | $6.31T | $3.93T | $5.91T |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $3.63T | $3.24T | $2.93T | $2.94T | $2.83T | $2.83T |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | $2.37T | $1.57T | $1.84T | $1.58T | $1.23T | $1.25T |
| Interest Expense | – | – | $4.51T | $2.22T | $560.36B | $747.90B |
| Tax Expense | $625.59B | $527.94B | $501.57B | $26.41B | -$14.51B | $444.95B |
| Net Income | $1.73T | $1.27T | $1.33T | $599.91B | -$83.32B | $1.12T |
| EPS (basic) | 151.7400 | 108.7100 | 110.8700 | 48.7000 | -6.5100 | 86.8800 |
| EPS (diluted) | 151.0900 | 108.1800 | 110.5800 | 48.3900 | -6.9300 | 86.5600 |
| Shares (diluted) | $11.40B | $11.65B | $11.98B | $12.32B | $12.80B | $12.86B |